Literature DB >> 3104450

Detection of mRNAs present at low concentrations in rat liver by in situ hybridization: application to the study of metabolic regulation and azo dye hepatocarcinogenesis.

E Lamas, A Kahn, A Guillouzo.   

Abstract

In situ hybridization on tissue sections was used to detect mRNAs present at low concentrations during metabolic adaptation and azo dye carcinogenesis in rat liver. The method consisted of hybridizing the slices at relatively high stringency with [35S]-labeled single-stranded probes derived from cDNA insert clones into the M13 phage. L-pyruvate kinase mRNA was proved to be present at very low concentrations in hepatocytes of fasted rats and to be relatively abundant in all hepatocytes after 18 hr of refeeding on a carbohydrate-rich diet. Aldolase A mRNA concentrations have been previously shown to increase markedly in liver of 3'-methyl DAB-fed rats, with a maximum at the fourth week. We demonstrate here, using our in situ hybridization technique, that this phenomenon is not due to re-expression of this "fetal marker" in hepatocytes but to its abundancy in proliferating small cells (i.e., so-called oval and transitional cells). Small amounts were also detected in sinusoidal cells. In normal liver, aldolase A mRNAs were detected only in some sinusoidal cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104450     DOI: 10.1177/35.5.3104450

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  10 in total

1.  Regulation of the multiple promoters of the human aldolase A gene: response of its two ubiquitous promoters to agents promoting cell proliferation.

Authors:  S Gautron; P Maire; V Hakim; A Kahn
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

Review 2.  Zonation of metabolism and gene expression in liver.

Authors:  K Jungermann
Journal:  Histochem Cell Biol       Date:  1995-02       Impact factor: 4.304

3.  Distribution of albumin, alpha 1-inhibitor 3 and their respective mRNAs in periportal and perivenous rat hepatocytes isolated by the digitonin-collagenase technique.

Authors:  L Racine; J Y Scoazec; A Moreau; P Chassagne; D Bernuau; G Feldmann
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

Review 4.  The diversity and plasticity of adult hepatic progenitor cells and their niche.

Authors:  Jiamei Chen; Long Chen; Mark A Zern; Neil D Theise; Ann Mae Diehl; Ping Liu; Yuyou Duan
Journal:  Liver Int       Date:  2017-02-23       Impact factor: 5.828

5.  Predominant periportal expression of the fructose 1,6-bisphosphatase gene in rat liver: dynamics during the daily feeding rhythm and starvation-refeeding cycle.

Authors:  F Eilers; S Modaressi; K Jungermann
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

6.  Zonal expression of the glucokinase gene in rat liver. Dynamics during the daily feeding rhythm and starvation-refeeding cycle demonstrated by in situ hybridization.

Authors:  F Eilers; H Bartels; K Jungermann
Journal:  Histochemistry       Date:  1993-02

7.  Predominant periportal expression of the phosphoenolpyruvate carboxykinase and tyrosine aminotransferase genes in rat liver. Dynamics during the daily feeding rhythm and starvation-refeeding cycle demonstrated by in situ hybridization.

Authors:  H Bartels; H Herbort; K Jungermann
Journal:  Histochemistry       Date:  1990

Review 8.  Activation of stem cells in hepatic diseases.

Authors:  T G Bird; S Lorenzini; S J Forbes
Journal:  Cell Tissue Res       Date:  2007-11-29       Impact factor: 5.249

9.  Predominant periportal expression of the phosphoenolpyruvate carboxykinase gene in liver of fed and fasted mice, hamsters and rats studied by in situ hybridization.

Authors:  H Bartels; S Freimann; K Jungermann
Journal:  Histochemistry       Date:  1993-04

10.  A Microfabricated Platform for Generating Physiologically-Relevant Hepatocyte Zonation.

Authors:  William J McCarty; O Berk Usta; Martin L Yarmush
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.